logo

Clinical Trial Calendar

Share
Company Name Axovant Sciences Ltd.
Event Name Top-line data from phase II study of Nelotanserin
Indication REM Behavior Disorder in subjects with Lewy Body Dementia
Outcome Date
Outcome
Result Date Q2 2018
News
http://investors.axovant.com/news-releases/news-release-details/axovant-announces-second-fiscal-quarter-financial-results-and
Return to Clinical Trial Calendar